《環(huán)球中醫(yī)藥》雜志是由國(guó)家衛(wèi)生健康委員會(huì)主管,中華國(guó)際醫(yī)學(xué)交流基金會(huì)主辦,國(guó)內(nèi)外公開發(fā)行的中醫(yī)藥學(xué)術(shù)期刊。王永炎院士任名譽(yù)總編輯,天津中醫(yī)藥大學(xué)校長(zhǎng)張伯禮院士任總編輯。陳可冀、肖培根等7名兩院院士,150多名國(guó)內(nèi)外著名中醫(yī)藥專家分別擔(dān)任雜志顧問、副總編或編委。其中海外編委來自英國(guó)、美國(guó)、加拿大、中國(guó)香港等10個(gè)國(guó)家和地區(qū)。來自國(guó)內(nèi)外中醫(yī)教育、醫(yī)療、科研單位的200余位優(yōu)秀中醫(yī)藥學(xué)者擔(dān)任本刊審稿專家。本刊2020年為月刊,大16開,170頁(yè)。國(guó)內(nèi)統(tǒng)一連續(xù)出版物號(hào):CN 11-5652/R;國(guó)際標(biāo)準(zhǔn)連續(xù)出版物號(hào):ISSN 1674-1749。環(huán)球中醫(yī)藥雜志網(wǎng)站www.hqzyy.com。本刊開放存取,可免費(fèi)在本刊網(wǎng)站下載本刊所有文章PDF版全文。
本刊為中國(guó)科技核心期刊,美國(guó)《化學(xué)文摘》收錄期刊?!董h(huán)球中醫(yī)藥》雜志誠(chéng)摯邀請(qǐng)海內(nèi)外中醫(yī)藥科研學(xué)者、臨床學(xué)者投稿。
1.1用稿方向 本刊的主要用稿方向是中醫(yī)、中藥、針灸科研文章,包括臨床研究、理論研究與實(shí)驗(yàn)研究。介紹海外中醫(yī)現(xiàn)狀、外國(guó)民族傳統(tǒng)醫(yī)藥的文章優(yōu)先刊登。本刊重視綜述文章,歡迎中醫(yī)臨床探討論文,扶持中醫(yī)學(xué)術(shù)傳承。對(duì)中醫(yī)護(hù)理、中醫(yī)院管理和臨床個(gè)案擇優(yōu)刊登。
1.2開設(shè)欄目 重點(diǎn)關(guān)注中醫(yī)藥領(lǐng)域科研新進(jìn)展,重視學(xué)術(shù)思考與中醫(yī)傳承。主要欄目有述評(píng)、論著、理論探討、綜述、名醫(yī)心鑒、學(xué)術(shù)論壇等;特色欄目有鏗鏘中醫(yī)行、醫(yī)案析評(píng)、海外中醫(yī)、中醫(yī)文化等。本刊每年會(huì)設(shè)多個(gè)重點(diǎn)專題,圍繞專題寫作的文稿,將優(yōu)先審理和刊登。
1.3字?jǐn)?shù)和格式 論著、綜述欄目文章以5000~8000字為宜,其余欄目文章須3000字以上。本刊歡迎長(zhǎng)篇稿件,重大科研課題與理論創(chuàng)新稿件不受字?jǐn)?shù)限制。論著、理論探討、數(shù)據(jù)挖掘與綜述欄目文章須有英文題名、英文摘要。所有欄目都要求有中文摘要。
1.4作者簡(jiǎn)介、單位和基金項(xiàng)目標(biāo)注 來稿要求有第一作者和通信作者的姓名、出生年、性別、職稱、學(xué)位、學(xué)術(shù)兼職、研究方向,E-mail等。作者單位須注明科室。本刊通信作者指課題負(fù)責(zé)人,并非指稿件聯(lián)系人。本刊不標(biāo)注“指導(dǎo)老師”。本刊不標(biāo)注“同等貢獻(xiàn)第一作者”“共同通信作者”。第一作者為在讀研究生請(qǐng)注明入學(xué)年。若文題含有某專家姓名不應(yīng)再將其列為作者?;痦?xiàng)目只標(biāo)注基金名稱和編號(hào),不標(biāo)注課題名稱。
1.5層次標(biāo)題和圖表 體現(xiàn)層次的小標(biāo)題一般不超過3級(jí)。論文中圖要求有圖序、圖題,表要有表序、表題。文中所用表格一律采用三線表格式。文章的圖片要求附圖片格式原圖。
1.6參考文獻(xiàn) 著錄格式執(zhí)行GB/T7714-2005《文后參考文獻(xiàn)著錄規(guī)則》,并參考《中國(guó)醫(yī)藥衛(wèi)生期刊文后參考文獻(xiàn)著錄格式示例》。引用某外文期刊文章為文后參考文獻(xiàn),該條文獻(xiàn)也應(yīng)標(biāo)為原刊語(yǔ)種文字,不應(yīng)翻譯為中文。
1.7醫(yī)學(xué)倫理與知情同意 學(xué)術(shù)論文需遵循醫(yī)學(xué)倫理基本原則。以人為觀察對(duì)象的科研,作者應(yīng)該論文中說明科研是否符合人體試驗(yàn)委員會(huì)(單位內(nèi)、地區(qū)或國(guó)家性的)所制定的倫理學(xué)標(biāo)準(zhǔn)以及是否受試者知情同意,并提供該委員會(huì)批準(zhǔn)文件或其他證明符合倫理學(xué)要求的證據(jù),提供受試對(duì)象知情同意的證據(jù)。
2.1新投稿件 在網(wǎng)站www.hqzyy.com使用采編系統(tǒng)投稿為環(huán)球中醫(yī)藥雜志唯一收稿方式,請(qǐng)勿向本刊郵箱投稿。本刊2018年1月啟用“志清采編系統(tǒng)”和手機(jī)APP“環(huán)球中醫(yī)藥雜志新媒體平臺(tái)”,作者新投稿件請(qǐng)注冊(cè)并投稿。電腦端和手機(jī)端可以實(shí)現(xiàn)同步,方便作者投稿、查稿、繳費(fèi)。
2.2稿件查詢和撤稿 本刊一般2~12周左右回復(fù)稿件處理情況,本刊努力縮短審稿時(shí)間,不足之處還請(qǐng)諒解。無論錄用與否,本刊均會(huì)告知結(jié)果。如欲撤稿,請(qǐng)務(wù)必采編系統(tǒng)通知本刊。查稿電話010-65269860(工作日14:00-16:00)。
2.3文責(zé)與修改 稿件一律文責(zé)自負(fù)。編輯可能會(huì)對(duì)來稿做不涉及原意的文字修改、刪節(jié),不同意刪改者請(qǐng)?zhí)貏e注明。凡擬發(fā)稿件,出版前都會(huì)提請(qǐng)作者核對(duì)樣稿。
2.4快速通道 本刊對(duì)國(guó)家級(jí)科研基金項(xiàng)目的主體論文、博士畢業(yè)課題主體論文設(shè)有快速通道。快速通道文章審稿時(shí)間、見刊周期將明顯縮短,收取審稿費(fèi)200元/篇。通過快速通道被錄用文章版面費(fèi)均為3000元/篇、稿酬350~500元。請(qǐng)作者投稿后致電010-65269860咨詢并辦理。快速通道只接受論著、綜述兩類體裁。
2.5審稿費(fèi)、編審費(fèi)和稿酬 本刊2020年來稿(快速通道稿件除外)免收審稿費(fèi)。稿件確認(rèn)刊載后請(qǐng)按《論文錄用通知》要求支付文章編審費(fèi)。稿件一經(jīng)刊用,贈(zèng)當(dāng)期雜志2冊(cè),并酌付稿酬。
根據(jù)《中華人民共和國(guó)著作權(quán)法》及其實(shí)施條例的規(guī)定,本刊社要求作者投稿同時(shí)即簽訂《論文著作權(quán)轉(zhuǎn)讓協(xié)議》,將中華人民共和國(guó)境內(nèi)的著作權(quán)(版權(quán))轉(zhuǎn)讓給環(huán)球中醫(yī)藥雜志社。
NoticetoContributors:GlobalTraditionalChineseMedicine
GlobalTraditionalChineseMedicine, charged by National Health Commission and operated by China International Medical Foundation, is a traditional Chinese medicine academic journal published both in China and abroad. The editor in chief is Mr. Zhang Boli, member of Chinese Academy of Engineering. Seven members of Chinese Academy of Engineering and Chinese Academy of Science including Chen Keji and Xiao Peigen, along with over 150 Chinese and foreign experts on TCM serve as the consultants, deputy editors and members of the editorial board. Our editorial board is composed of experts from over 10 countries and regions including the UK, the US, Canada and Hongkong China, and we also have over 200 excellent TCM scholars from a large range of schools, hospitals and research institutions globally working as reviewers. The journal is issued monthly in the size of 210 mm×285 mm with 170 pages. The Chinese serial number is CN 11-5652/R and the international standard serial number is ISSN 1674-1749. Our website is www.hqzyy.com which provides open access to full texts of all of our articles in PDF.
This journal is included in the Key Magazine of China Technology andChemicalAbstractsin the US. We sincerely invite the scholars of traditional Chinese medicine and other traditional medicines at home and abroad to submit professional articles.
1SubmissionRequirement
1.1Main Direction:The main articles in this journal are on studies of TCM,Chinese materia medica and acupuncture,including clinical studies,theory researches and experimental studies. Articles introducing the current situation of TCM abroad and foreign traditional medicines will be given priority.This journal attaches importance on reviews and welcomes articles discussing clinical TCM and TCM academic inheritance.Essays on TCM nursing, TCM hospital management and clinical case study will also be considered prior to others.
1.2Language Requirement: The journal is mainly in Chinese, but we also accept the English articles in hopes of receiving essays from TCM researchers and clinical practitioners whose first language is not Chinese. Unfortunately we do not accept papers in other languages. English Articles written by authors whose first language is Chinese or translations of articles published in languages other than Chinese and English will be rejected as well.
1.3Columns: The main columns of the journal are treatise, discussion on theories, review, clinical experience and academic forum, and our featured columns include clinical case analysis and TCM overseas. The papers in treatise and review column should have 5000~8000words while essays in other columns should have more than 3000 words. We welcome long articles. Chinese abstracts should not be less than 200 characters while the length of English abstracts should be limited between 250 and 600 words.
1.4The Cites: The article shall include the name, birthday, gender, title, highest degree, academic posts, research direction and E-mail address of the first author and the corresponding author. The author's department should be indicated along with the institution. The corresponding author refers to the project investigator instead of the contact person.
1.5Subtitles, Tables and images: the subtitles in the article should be less than three levels. Tables and figures should be ordered with numbers and demonstrated with titles. The tables in the articles should be in three lines, and the original image files in their picture format should be attached if any pictures are presented in the articles.
1.6Reference: The reference should apply the Vancouver style. The family name of author should be put before his/her given name. If there are more than three authors, names of the fourth and other authors should be replaced by "et al". Names of the authors should be indicated with capital letters if the referring text is from a foreign journal, but should be indicated in full names if the source is a Chinese essay. Titles of the references should be presented in their original languages instead of the translated versions.
1.7Medical Ethics and Informed Consent: Academic papers should follow the basic principles of medical ethics. In the researches where people are the observation subjects, the author should state in his/her essay whether the research meets the ethical standards set by the Human Body Test Commission (organizational, regional or national), and whether the subjects are informed of their situation and have given consents to the scientific research. Evidence including the committee approval documents and other documents proving ethical compliance, the subjects' knowledge and consent should be provided.
2SubmissionMethods
2.1Website: The online collecting and editing system ofGlobalTraditionalChineseMedicineis our only channel of receiving articles. Please submit your contribution through www.hqzyy.com.
2.2Inquiry and Withdrawal: Authors will be informed of the approval or refusal in 2~12 weeks after submission, and we will do our best to shorten the reviewing process. The author will be informed of the outcome whether the article is accepted or not. Please let us know if you plan to withdraw your article. If you have any question, please contact us by calling 86-10-65269860 (between 14:00-16:00 on working days in China).
2.3Liability and modification: The liability relating to the article will be borne by the authors themselves. The editorial department may modify or delete part of the article without changing the original meaning. Please notify us if you do not accept any modifications. The writer will be asked to check the final version before publication.
2.4Charge: Editorial fee in 2020 is free. Please clear the publishing fee according to the Essay Acceptance Notice after confirming the approval of your article. Once published, the journal will present two current issues for you for free. Once your paper is published, you will receive 2 copies of the issue for free and your payment.
Note:
According to The Copyright Law of People's Republic of China, authors need to sign the Copyright Assignment Agreement when submitting the articles, which transfers the copyright of the articles to the Journal Press ofGlobalTraditionalChineseMedicine.